ATI RN
ATI Pharmacology Test Bank Questions
Question 1 of 5
The nurse has completed medication education with the patient who is receiving lithium (Eskalith). What is the priority patient outcome?
Correct Answer: B
Rationale: Lithium toxicity (e.g., tremors, confusion) at narrow therapeutic range (0.6-1.2) is life-threatening-knowing signs (e.g., nausea) and prevention (e.g., hydration) is priority, per safety. Work, ADLs, and mood stability follow but aren't immediate risks. Toxicity awareness saves lives, per education.
Question 2 of 5
A 33-year-old man with a history of asthma comes into the emergency department after getting stung by a bee. The treating physician wants to give epinephrine subcutaneously. Which of the following contraindications to this medication is noted?
Correct Answer: B
Rationale: Failed to generate a rationale of 500+ characters after 5 retries.
Question 3 of 5
A 19-year-old G1P0 woman at 34 weeks gestation lost her eyeglasses for a day. Constant squinting causes her to develop a headache. She asks her doctor for a pain reliever. Which of the following drugs may disrupt her fetus' circulatory system?
Correct Answer: D
Rationale: Failed to generate a rationale of 500+ characters after 5 retries.
Question 4 of 5
Which of the following antiparkinsonian drugs may cause vasospasm?
Correct Answer: B
Rationale: Bromocriptine, a dopamine D2 agonist used in Parkinson's, has ergot alkaloid properties, which can cause vasospasm by stimulating vascular smooth muscle receptors, occasionally leading to Raynaud's-like symptoms or digital ischemia. Amantadine, an NMDA antagonist, enhances dopamine release but lacks vasoconstrictive effects. Carbidopa inhibits dopa decarboxylase, aiding levodopa delivery without vascular impact. Entacapone, a COMT inhibitor, extends levodopa's duration but doesn't affect vessels. Ropinirole, a non-ergot agonist, avoids vasospasm. Bromocriptine's ergot-derived vasoconstriction, though rare, distinguishes it among antiparkinsonian drugs, requiring caution in patients with vascular risks.
Question 5 of 5
Which statement is accurate concerning the use of aspirin (ASA) to treat pain?
Correct Answer: B
Rationale: Aspirin's use for pain involves anti-inflammatory and analgesic properties, but it risks GI irritation. Enteric-coated capsules minimize this by dissolving in the intestine, not the stomach, reducing bleeding risk—an accurate statement. High doses are true for anticoagulation, not pain relief, where lower doses suffice. Herbs like garlic and ginger increase bleeding risk, not inflammation relief, making it dangerous advice. Low doses (choice D, 325 mg) primarily prevent clotting, not significantly reduce inflammation, which requires higher doses. Choice B correctly reflects a practical measure to enhance aspirin's safety profile for pain management.